MDWD
MediWound Ltd

1,831
Mkt Cap
$228.99M
Volume
269,988.00
52W High
$22.51
52W Low
$14.14
PE Ratio
-6.77
MDWD Fundamentals
Price
$16.86
Prev Close
$17.86
Open
$17.50
50D MA
$18.08
Beta
0.83
Avg. Volume
70,098.87
EPS (Annual)
-$3.03
P/B
9.65
Rev/Employee
$182,180.18
Loading...
Loading...
News
all
press releases
MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates
MediWound (MDWD) delivered earnings and revenue surprises of +70.37% and -15.52%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8h ago
News Placeholder
More News
News Placeholder
IGC Pharma, Inc. (IGC) Reports Q2 Loss, Misses Revenue Estimates
IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of 0.00% and -56.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
MediWound (NASDAQ:MDWD) Upgraded by Zacks Research to Hold Rating
Zacks Research raised shares of MediWound from a "strong sell" rating to a "hold" rating in a report on Tuesday...
MarketBeat·6d ago
News Placeholder
RenovoRx, Inc. (RNXT) Reports Q3 Loss, Lags Revenue Estimates
RenovoRx (RNXT) delivered earnings and revenue surprises of 0.00% and -35.12%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
MediWound (MDWD) Expected to Announce Earnings on Thursday
MediWound (NASDAQ:MDWD) will be releasing its Q3 2025 earnings before the market opens on Thursday, November 20. (View Earnings Report at...
MarketBeat·8d ago
News Placeholder
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates
Journey Medical (DERM) delivered earnings and revenue surprises of -12.50% and -0.39%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8d ago
News Placeholder
FibroGen (FGEN) Reports Q3 Loss, Lags Revenue Estimates
FibroGen (FGEN) delivered earnings and revenue surprises of +59.85% and -34.39%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
MediWound Ltd. $MDWD is Yelin Lapidot Holdings Management Ltd.'s 9th Largest Position
Yelin Lapidot Holdings Management Ltd. decreased its holdings in shares of MediWound Ltd. (NASDAQ:MDWD - Free Report) by 4.8% during the second quarter, according to its most recent disclosure with...
MarketBeat·12d ago
News Placeholder
Nektar Therapeutics (NKTR) Reports Q3 Loss, Beats Revenue Estimates
Nektar (NKTR) delivered earnings and revenue surprises of +35.09% and +11.42%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates
MediWound (MDWD) delivered earnings and revenue surprises of -123.64% and +1.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago

Latest MDWD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.